Description
XENGLU-MET 12.5mg + 1000mg Tablets 14’s combine Sitagliptin (12.5mg) and Metformin Hydrochloride (1000mg) to provide effective management of type 2 diabetes mellitus. This combination medication works through complementary mechanisms to improve blood sugar control.
Sitagliptin, a Dipeptidyl Peptidase-4 (DPP-4) inhibitor, enhances the body’s incretin system to increase insulin secretion and reduce glucagon levels. Metformin decreases glucose production in the liver and improves insulin sensitivity, helping the body use glucose more efficiently.
XENGLU-MET is typically prescribed for patients who require better glycemic control beyond diet and exercise alone, especially when monotherapy is insufficient.
Key Benefits:
-
Dual-action formula targeting blood sugar regulation
-
Enhances insulin release and reduces liver glucose production
-
Supports improved glycemic control in type 2 diabetes
-
Convenient oral tablets for once or twice daily dosing
Usage Instructions: Take as directed by your healthcare provider, usually with meals to reduce gastrointestinal side effects. Do not crush or chew tablets.
Precautions: Consult your doctor before use if you have kidney or liver issues. Inform your healthcare provider about all medications to avoid interactions.
Reviews
There are no reviews yet.